Oruka Therapeutics, Inc. (ORKA)
93.55
+1.35
(+1.46%)
USD |
NASDAQ |
Sep 16, 16:00
94.44
+0.89
(+0.95%)
After-Hours: 07:57
Oruka Therapeutics Total Assets (Quarterly) : 1.139B for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.139B |
| March 31, 2026 | 504.48M |
| December 31, 2025 | 488.62M |
| September 30, 2025 | 509.25M |
| June 30, 2025 | 357.42M |
| March 31, 2025 | 377.11M |
| December 31, 2024 | 396.02M |
| September 30, 2024 | 414.09M |
| June 30, 2024 | 33.84M |
| March 31, 2024 | 36.71M |
| December 31, 2023 | 37.86M |
| September 30, 2023 | 39.18M |
| June 30, 2023 | 41.08M |
| March 31, 2023 | 42.06M |
| December 31, 2022 | 43.08M |
| September 30, 2022 | 44.96M |
| June 30, 2022 | 48.10M |
| March 31, 2022 | 51.01M |
| December 31, 2021 | 54.92M |
| September 30, 2021 | 60.19M |
| June 30, 2021 | 65.34M |
| March 31, 2021 | 69.18M |
| December 31, 2020 | 50.43M |
| September 30, 2020 | 51.98M |
| June 30, 2020 | 11.63M |
| Date | Value |
|---|---|
| March 31, 2020 | 7.461M |
| December 31, 2019 | 8.536M |
| September 30, 2019 | 9.949M |
| June 30, 2019 | 10.39M |
| March 31, 2019 | 8.606M |
| December 31, 2018 | 6.825M |
| September 30, 2018 | 8.445M |
| June 30, 2018 | 10.07M |
| March 31, 2018 | 12.79M |
| December 31, 2017 | 12.36M |
| September 30, 2017 | 16.92M |
| June 30, 2017 | 17.30M |
| March 31, 2017 | 20.59M |
| December 31, 2016 | 24.63M |
| September 30, 2016 | 28.68M |
| June 30, 2016 | 32.64M |
| March 31, 2016 | 36.93M |
| December 31, 2015 | 39.57M |
| September 30, 2015 | 42.40M |
| June 30, 2015 | 45.12M |
| March 31, 2015 | 13.26M |
| December 31, 2014 | 16.13M |
| September 30, 2014 | 18.04M |
| June 30, 2014 | 20.54M |
| March 31, 2014 | 22.66M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Tenax Therapeutics, Inc. | 121.66M |
| Manhattan Scientifics, Inc. | -- |
| Exicure, Inc. | 11.40M |
| Century Therapeutics, Inc. | 287.01M |
| Absci Corp. | 268.92M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 24.84M |
| Shareholders Equity (Quarterly) | 1.115B |
| Debt to Equity Ratio | 0.0023 |
| Current Ratio | 38.51 |
| Net Debt Paydown Yield | -0.01% |